Valuation: Medios AG

Market Cap 304M 348M 280M 261M 495M 33.15B 502M 3.36B 1.31B 16.29B 1.31B 1.28B 56.15B P/E 2026 *
11.3x
P/E 2027 * 8.89x
Enterprise Value 381M 435M 350M 326M 618M 41.44B 628M 4.2B 1.63B 20.37B 1.63B 1.6B 70.2B EV / Sales 2026 *
0.18x
EV / Sales 2027 * 0.16x
Free-Float
92.4%
Yield 2026 *
-
Yield 2027 * -
1 day+1.47%
1 week+2.81%
Current month+2.81%
1 month-2.20%
3 months+0.32%
6 months-15.40%
Current year-14.23%
1 week 12.02
Extreme 12.02
12.58
1 month 11.8
Extreme 11.8
13
Current year 11.64
Extreme 11.64
17.44
1 year 11.64
Extreme 11.64
17.44
3 years 9.98
Extreme 9.98
18.5
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
Manager TitleAgeSince
Chief Executive Officer 58 01/02/2026
Director of Finance/CFO 54 15/04/2026
Investor Relations Contact - -
Director TitleAgeSince
Chairman 53 07/11/2014
Director/Board Member 65 14/09/2016
Director/Board Member 58 01/01/2024
Date Insider Type Main position Quantity % Market Cap.
02-04Sell

Chief Executive Officer

13,638 0.0535%
01-22Buy

Executive/Senior Manager

4,000 0.0157%
19/08/24Buy

Executive/Senior Manager

10,000 0.0392%
Change 5-day change 1-year change 3-year change Capi.($)
+1.47%+2.81%-1.90%-25.98% 348M
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+31.35%+24.29% 338B
-0.56%+0.96%+39.86%+36.64% 299B
-0.08%+1.30%+30.37%+44.02% 291B
-1.54%+2.81%-27.56%-39.45% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +2.03%+4.40%+27.71%+49.44% 369.27B
Weighted average by Cap. +2.25%+5.53%+41.78%+83.00%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.91B 1.78B 3.38B 227B 3.43B 22.96B 8.93B 111B 8.94B 8.75B 384B 2.14B 2.45B 1.96B 1.83B 3.47B 233B 3.53B 23.59B 9.17B 114B 9.18B 8.98B 394B
Net income 27.41M 31.35M 25.19M 23.48M 44.53M 2.99B 45.2M 302M 118M 1.47B 118M 115M 5.06B 34.51M 39.47M 31.71M 29.56M 56.07M 3.76B 56.92M 381M 148M 1.85B 148M 145M 6.37B
Net Debt 76.15M 87.11M 69.98M 65.23M 124M 8.29B 126M 840M 327M 4.08B 327M 320M 14.05B 40.72M 46.58M 37.42M 34.88M 66.17M 4.44B 67.17M 449M 175M 2.18B 175M 171M 7.51B
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
993
Date Price Change Volume
03/07/26 €12.42 +1.47% 10,480
02/07/26 €12.24 +0.99% 12,984
01/07/26 €12.12 +0.33% 20,361
30/06/26 €12.08 -0.33% 26,862
29/06/26 €12.12 +0.33% 47,058
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
12.42EUR
Average target price
23.00EUR
Spread / Average Target
+85.19%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILM1 Stock